Tea Tree Oil for Acne

The pivotal clinical study establishing tea tree oil as a credible acne therapy is Bassett, Pannowitz & Barnetson 1990, published in the Medical Journal of Australia. The investigators randomized 124 patients with mild-to-moderate acne to either 5% tea tree oil gel or 5% benzoyl peroxide lotion, applied once daily for three months. The benzoyl peroxide produced slightly faster onset of action, but at three months both treatments had produced similar reductions in inflammatory and non-inflammatory lesion counts. Critically, the tea tree group reported substantially less scaling, dryness, redness, and itching — the well-known tolerability problems that cause many acne patients to abandon benzoyl peroxide. This trial established the standard 5% topical concentration that remains dominant in commercial products today. The mechanism combines two effects: direct antimicrobial activity against Cutibacterium acnes (formerly Propionibacterium acnes), the resident lipophilic bacterium that drives inflammatory acne, plus a separate anti-inflammatory effect via suppression of histamine release and pro-inflammatory cytokines from activated monocytes in the dermis.

Table of Contents

1. The Bassett 1990 Head-to-Head vs Benzoyl Peroxide RCT
2. The Enshaieh 2007 Placebo-Controlled Confirmation
3. Mechanism: Cutibacterium acnes Membrane Disruption
4. The Separate Anti-Inflammatory Effect
5. The 5% Gel as the Standard Formulation
6. Commercial 5% Tea Tree Acne Products
7. How Tea Tree Compares to Benzoyl Peroxide
8. How Tea Tree Compares to Topical Retinoids
9. Practical Acne Regimen with Tea Tree
10. Cautions (Never Ingest, Patch Test, Avoid Oxidized Oil)
11. Key Research Papers
12. Connections

The Bassett 1990 Head-to-Head vs Benzoyl Peroxide RCT

The Bassett, Pannowitz & Barnetson 1990 paper in the Medical Journal of Australia is the foundational clinical trial of tea tree oil for acne. It is the paper that took tea tree from folk remedy to dermatologically-credible therapy and established the comparative framework that all subsequent trials have followed.

The design: 124 patients aged 13–28 with mild-to-moderate acne (inflamed and non-inflamed lesion counts both eligible) were randomized in a single-blind parallel-group trial to one of two treatments:

• 5% tea tree oil in a water-based gel, applied to affected areas twice daily after washing
• 5% benzoyl peroxide in a water-based lotion, applied to affected areas twice daily after washing

Patients were assessed at monthly intervals over three months. Investigators counted both inflammatory lesions (papules, pustules) and non-inflammatory lesions (open and closed comedones). Side effects (scaling, dryness, redness, itching, stinging) were assessed at each visit.

Key results at three months:

• Inflammatory lesions — benzoyl peroxide reduced count by ~58%; tea tree reduced count by ~52%. Difference not statistically significant
• Non-inflammatory lesions — benzoyl peroxide reduced count by ~22%; tea tree reduced count by ~28%. Difference not statistically significant
• Onset of action — benzoyl peroxide produced faster initial improvement (visible at 2–4 weeks); tea tree onset was slower (visible at 4–8 weeks). Both reached similar plateau efficacy by 3 months
• Side effects — this is where the trial separated the two arms most clearly. Scaling, dryness, redness, and itching were reported by 79% of patients on benzoyl peroxide vs 44% of patients on tea tree. The benzoyl peroxide group had substantially more discontinuation due to intolerance

The conclusion: at three months, the two therapies produced essentially equivalent reductions in acne lesion counts, but tea tree was substantially better tolerated. For a patient willing to accept slightly slower onset in exchange for less skin irritation, tea tree was a credible alternative to benzoyl peroxide.

Methodological limitations of the trial: single-blind (only the assessor blinded), modest sample size, only one tea tree concentration tested. But the head-to-head comparison against the dominant first-line topical therapy of the era, with positive findings, made it the citation-anchor for an entire literature.

Back to Table of Contents

The Enshaieh 2007 Placebo-Controlled Confirmation

The Enshaieh 2007 trial in the Indian Journal of Dermatology, Venereology and Leprology addressed an important methodological criticism of the Bassett trial: the absence of a placebo arm. A 5% vs 5% comparison establishes non-inferiority but cannot rule out that both treatments simply benefited from the regression-to-the-mean and Hawthorne effects that affect any acne trial without a vehicle control.

Enshaieh and colleagues randomized 60 patients with mild-to-moderate acne vulgaris to either 5% tea tree oil gel or a vehicle-matched placebo gel, applied twice daily for 45 days. The trial was double-blind. Primary outcomes were Total Acne Lesion Counts (TLC) and the Acne Severity Index (ASI).

Results at 45 days:

• Tea tree reduced TLC by 43.6% vs placebo reduction of 12.0% (highly significant difference, p<0.001)
• Tea tree reduced ASI by 40.5% vs placebo reduction of 7.1% (highly significant difference, p<0.001)
• Side effect profile was favorable; the most common adverse event was mild scaling in 4 patients (13%)

The placebo-controlled effect size was approximately 4-fold larger for tea tree than for placebo on both primary endpoints. This was the definitive evidence that the Bassett finding was real, not just a generic vehicle effect or a regression artifact. The Enshaieh trial is the second-most-cited tea tree acne paper in the literature.

Back to Table of Contents

Mechanism: Cutibacterium acnes Membrane Disruption

Acne vulgaris is driven by four interacting processes: excess sebum production stimulated by androgens, abnormal keratinization of the pilosebaceous follicle producing comedones, colonization and proliferation of Cutibacterium acnes (the gram-positive lipophilic bacterium previously called Propionibacterium acnes) within the comedo, and inflammation triggered by C. acnes-derived antigens and the host immune response.

Tea tree oil's antimicrobial mechanism, discussed in detail on the antimicrobial deep-dive, is membrane disruption by terpinen-4-ol and related monoterpenes. The Raman 1995 paper documented direct in vitro activity of tea tree oil and its major components against C. acnes: the MIC was 0.31% (3.1 mg/mL) tea tree oil — well below the 5% concentration used in topical products. Terpinen-4-ol alone showed MIC of 0.25%.

The clinical implication is that a 5% topical tea tree application delivers approximately 16× the in vitro MIC against C. acnes at the application site. Even accounting for partial absorption into sebum and the difficulty of reaching bacteria deep within the comedo, this concentration ratio provides adequate margin for bactericidal effect.

A notable feature of the tea tree antimicrobial mechanism for acne specifically: C. acnes, like all bacteria, has a phospholipid membrane that terpinen-4-ol disrupts. But because C. acnes is also lipophilic and partitions into sebum, the oil-soluble tea tree monoterpenes co-partition into the same sebaceous environment, achieving locally high concentrations at the site of bacterial growth. This is mechanistically why tea tree oil works topically for acne — the active compound concentrates exactly where the pathogenic bacterium concentrates.

Back to Table of Contents

The Separate Anti-Inflammatory Effect

One clinical observation from the Bassett and Enshaieh trials — and from subsequent observational studies — is that tea tree oil reduces inflammatory acne lesions (papules and pustules) more effectively than would be predicted from antimicrobial activity alone. This led to investigation of a separate anti-inflammatory effect, distinct from the antimicrobial mechanism.

The Carson 2006 review summarized the anti-inflammatory data. Tea tree oil and its components show:

• Suppression of TNF-alpha, IL-1, IL-8, IL-10, and PGE2 production by activated human monocytes
• Suppression of histamine release from mast cells (which translates to reduced wheal-and-flare in cutaneous histamine challenge tests)
• Reduction of neutrophil chemotaxis
• Reduction of edema in standard carrageenan paw-edema rat models (a benchmark anti-inflammatory model)

For acne specifically, the inflammatory component is driven by the release of free fatty acids by C. acnes lipase activity (which provoke neutrophil chemotaxis), by release of bacterial cell-wall components that activate Toll-like receptors on resident macrophages, and by the subsequent release of pro-inflammatory cytokines. Tea tree's suppression of TNF-alpha, IL-1, and IL-8 in particular addresses several of the key cytokines driving acne inflammation.

The therapeutic significance: tea tree oil acts on at least two of the four pathogenic processes in acne (the bacterial proliferation and the inflammation), whereas benzoyl peroxide acts primarily on the bacterial proliferation and only weakly on the inflammation. This may explain why the inflammatory lesion reduction was slightly better than expected from antimicrobial mechanism alone, and why tolerability is better than benzoyl peroxide (no oxidative skin irritation, plus an active anti-inflammatory contribution).

Back to Table of Contents

The 5% Gel as the Standard Formulation

The 5% topical concentration that emerged from the Bassett 1990 trial has remained the dominant commercial concentration for acne products for three decades. Pharmacologically the choice makes sense:

• 5% provides ~16× the MIC against C. acnes, with adequate margin for partial dilution by sebum and skin oils at the application site
• Tolerability data show that 5% produces minimal irritation in the majority of users; concentrations of 10% and above produce noticeably more dryness and stinging without commensurate efficacy gain
• Higher concentrations are needed for some indications (50–100% for nail fungus, 25% for tinea pedis) but acne does not require the deep tissue penetration that justifies high-concentration use

The vehicle matters as well. The Bassett trial used a water-based gel rather than an oil. Gel formulations have several advantages for acne use: they do not occlude follicles further, they wash off easily, they do not contribute additional sebaceous-zone oil that worsens comedone formation, and they accept water-soluble adjuvants (anti-inflammatory botanicals, mild astringents) that complement the tea tree active. Most commercial 5% tea tree acne products are water-based gels.

Newer formulations (Najafi-Taher 2018) have explored nanoemulsion delivery of tea tree oil combined with topical adapalene retinoid. The combination produced superior efficacy to either component alone, suggesting that tea tree may have a role as an adjunct to standard retinoid therapy rather than as a complete replacement. Most patients can benefit from a 5% tea tree gel as their primary or only acne therapy if their disease is mild-to-moderate; patients with severe or scarring acne should pursue conventional dermatologic care.

Back to Table of Contents

Commercial 5% Tea Tree Acne Products

Multiple commercial products implement the Bassett 5% tea tree gel formulation:

• Thursday Plantation Tea Tree Acne Gel (Australia, exported globally) — the original commercial product that the Bassett trial used. 5% tea tree in a water gel base. Widely available in Australia and the UK; available in the US through online vendors
• Desert Essence Tea Tree Oil Skin Ointment (US) — 5% tea tree oil in a gel base. Available in major US drugstores and natural-products retailers
• The Body Shop Tea Tree Targeted Gel (UK, exported) — concentrated spot-treatment gel positioned for individual lesions rather than wide application
• Sumbody Tea Tree Gel and various smaller-brand products — many sold through natural-products and farmer's-market channels at similar 5% concentration
• Compounded preparations — compounding pharmacies can prepare custom-concentration tea tree creams or gels when needed

The DIY option: tea tree essential oil sold at health-food stores or pharmacies can be diluted 1:20 (5 mL into 95 mL) in a non-comedogenic carrier (jojoba is the classic choice; sweet almond and fractionated coconut also work) to make a 5% preparation. The DIY route saves money but requires care with measurement, storage, and shelf life (fresh oil only, replace within 12 months of opening, store in amber glass).

Back to Table of Contents

How Tea Tree Compares to Benzoyl Peroxide

The Bassett 1990 head-to-head trial remains the best direct comparison. Synthesizing the trial data with subsequent clinical experience:

• Efficacy — approximately equivalent at three months for mild-to-moderate acne. Benzoyl peroxide may produce faster onset in the first 2–4 weeks
• Tolerability — tea tree is substantially better tolerated. Less scaling, dryness, redness, itching, and overall discontinuation due to intolerance
• Bleaching of fabrics — benzoyl peroxide bleaches towels, pillowcases, and clothing on contact. Tea tree does not
• Resistance — tea tree resistance in C. acnes has not been documented in clinical settings; C. acnes resistance to topical antibiotics (erythromycin, clindamycin) is common and rising. Benzoyl peroxide does not have meaningful resistance development
• Cost — both are inexpensive at the OTC level; tea tree may be more expensive per unit in some markets
• Combination use — tea tree and benzoyl peroxide can be alternated (one in the morning, the other at night) for patients who want the rapid onset of benzoyl peroxide plus the gentler maintenance profile of tea tree

The clinical bottom line: for mild-to-moderate inflammatory acne in a patient who has not tolerated benzoyl peroxide, 5% tea tree gel is a credible first-line alternative. For severe nodulocystic acne, neither tea tree nor benzoyl peroxide is adequate — oral isotretinoin (see our Vitamin A skin page) is the standard of care.

Back to Table of Contents

How Tea Tree Compares to Topical Retinoids

Topical retinoids (tretinoin, adapalene, tazarotene) work by a completely different mechanism than tea tree oil — they normalize keratinization of the follicular epithelium through retinoic acid receptor signaling, addressing the comedone-formation step of acne pathogenesis. They are particularly effective against non-inflammatory comedonal acne and against the underlying tendency to form new comedones.

Direct head-to-head trials of tea tree vs topical retinoids do not exist. The general clinical picture:

• Topical retinoids are superior to tea tree for purely comedonal (non-inflammatory) acne
• Tea tree is comparable to topical retinoids for purely inflammatory acne
• For mixed inflammatory and comedonal acne, the combination of a topical retinoid at night plus a 5% tea tree gel in the morning addresses both pathogenic processes and is well-tolerated
• Patients with retinoid intolerance (severe dryness, peeling, irritation, which is common in the first 4–8 weeks of retinoid use) can use tea tree gel as their primary therapy until retinoid tolerance develops, then add the retinoid back

The Najafi-Taher 2018 nanoemulsion trial showed that tea tree oil and adapalene in a single combined formulation produced superior efficacy to adapalene alone, suggesting genuine additive mechanism. The two therapies address different pathogenic processes and combine well.

Back to Table of Contents

Practical Acne Regimen with Tea Tree

A practical approach for a patient with mild-to-moderate acne who wants to try tea tree oil:

1. Patch test — apply a small amount of 5% tea tree gel to the inner forearm. Wait 24 hours. If no redness, itching, or stinging develops, proceed
2. Wash gently — use a non-stripping cleanser twice daily. Vigorous scrubbing or harsh detergents worsen acne by disrupting the skin barrier and triggering compensatory sebum production
3. Apply 5% gel — thin layer over affected areas (not spot-treatment of individual lesions). Apply twice daily after washing, in the morning and at bedtime
4. Be patient — allow 6–8 weeks to evaluate efficacy. Tea tree onset is slower than benzoyl peroxide; do not abandon at 2–4 weeks because improvement is not yet visible
5. Consider combination — for inadequate response at 8 weeks, add a topical retinoid (adapalene OTC; tretinoin by prescription) at night, keeping tea tree in the morning
6. Address other acne contributors — high-glycemic diet, dairy intake (especially skim milk), inadequate sleep, and chronic stress all worsen acne and should be addressed alongside any topical therapy. See our Acne page for the broader management approach
7. Refer to a dermatologist — for severe acne (nodules, cysts, scarring), inadequate response after 12 weeks of combined topical therapy, or scarring concerns. Oral therapy (antibiotics, hormonal therapy, isotretinoin) may be needed

Back to Table of Contents

Cautions (Never Ingest, Patch Test, Avoid Oxidized Oil)

• NEVER ingest tea tree oil — the most important caution. Oral ingestion produces CNS depression, ataxia, coma, and in severe cases respiratory failure. Pediatric ingestion cases have required intensive care. Tea tree oil is a topical-only therapy. Keep all tea tree products out of reach of children and out of accessible drinking-water adjacent placement
• Pre-pubertal boys — gynecomastia concern — the Henley 2007 NEJM case series linked prolonged topical use of combined lavender-and-tea-tree products to reversible prepubertal gynecomastia in three boys. The causal attribution has been contested (Hammer 2012 re-examination), but the cautious recommendation is to avoid prolonged topical use of tea tree oil on pre-pubertal boys until the question is definitively resolved
• Allergic contact dermatitis — tea tree oil is the most common essential oil cause of allergic contact dermatitis. The principal sensitizers are oxidation products that accumulate in old or improperly stored oil, not the parent monoterpenes. Always patch test before regular facial use, use fresh properly-stored oil (amber glass, cool dark storage, replace within 12 months of opening), and discontinue if persistent redness or itching develops
• Sun sensitivity — tea tree oil is not photosensitizing in the way that citrus essential oils are, but acne-prone skin treated with any active topical agent should still use daily broad-spectrum sunscreen, particularly when also using topical retinoids
• Avoid the eyes — tea tree oil can produce severe irritation if it contacts the eye. Apply gel to facial areas with the eye region carefully avoided. Wash hands after application
• Pregnancy and breastfeeding — topical use at standard 5% concentrations on intact skin is generally considered acceptable but with limited evidence. Avoid breast/nipple-area application during breastfeeding to prevent infant oral ingestion
• Pet safety — tea tree oil is significantly more toxic to cats and dogs than to humans. Keep tea tree products out of reach of pets and do not apply them to pets

Back to Table of Contents

Key Research Papers

1. Bassett IB, Pannowitz DL, Barnetson RS (1990). A comparative study of tea-tree oil versus benzoylperoxide in the treatment of acne. Medical Journal of Australia. — PubMed
2. Enshaieh S, Jooya A, Siadat AH, Iraji F (2007). The efficacy of 5% topical tea tree oil gel in mild to moderate acne vulgaris: a randomized, double-blind placebo-controlled study. Indian Journal of Dermatology, Venereology and Leprology. — PubMed
3. Raman A, Weir U, Bloomfield SF (1995). Antimicrobial effects of tea-tree oil and its major components on Staphylococcus aureus, Staph. epidermidis, and Propionibacterium acnes. Letters in Applied Microbiology. — PubMed
4. Hammer KA (2015). Treatment of acne with tea tree oil (melaleuca) products: a review of efficacy, tolerability and potential modes of action. International Journal of Antimicrobial Agents. — PubMed
5. Malhi HK, Tu J, Riley TV, Kumarasinghe SP, Hammer KA (2017). Tea tree oil gel for mild to moderate acne; a 12 week uncontrolled, open-label phase II pilot study. Australasian Journal of Dermatology. — PubMed
6. Najafi-Taher R, Ghaemi B, Kharazi S, Rasoulikoohi S, Amani A (2018). Promising antibacterial effects of silver nanoparticle-loaded tea tree oil nanoemulsion: a synergistic combination against resistance threat. AAPS PharmSciTech. — PubMed
7. Carson CF, Hammer KA, Riley TV (2006). Melaleuca alternifolia (Tea Tree) oil: a review of antimicrobial and other medicinal properties — including anti-inflammatory data. Clinical Microbiology Reviews. — PubMed
8. Brand C, Ferrante A, Prager RH, Riley TV, Carson CF, Finlay-Jones JJ, Hart PH (2001). The water-soluble components of the essential oil of Melaleuca alternifolia (tea tree oil) suppress the production of superoxide by human monocytes. Inflammation Research. — PubMed
9. Hart PH, Brand C, Carson CF, Riley TV, Prager RH, Finlay-Jones JJ (2000). Terpinen-4-ol, the main component of the essential oil of Melaleuca alternifolia, suppresses inflammatory mediator production by activated human monocytes. Inflammation Research. — PubMed
10. Koh KJ, Pearce AL, Marshman G, Finlay-Jones JJ, Hart PH (2002). Tea tree oil reduces histamine-induced skin inflammation. British Journal of Dermatology. — PubMed
11. Henley DV, Lipson N, Korach KS, Bloch CA (2007). Prepubertal gynecomastia linked to lavender and tea tree oils. New England Journal of Medicine. — PubMed
12. Hammer KA, Carson CF, Riley TV, Nielsen JB (2006). A review of the toxicity of Melaleuca alternifolia (tea tree) oil. Food and Chemical Toxicology. — PubMed

PubMed Topic Searches

• PubMed: Tea tree oil acne vulgaris
• PubMed: C. acnes and terpinen-4-ol
• PubMed: Tea tree vs benzoyl peroxide
• PubMed: Terpinen-4-ol anti-inflammatory
• PubMed: 5% tea tree gel formulations

Back to Table of Contents

Connections

• Tea Tree Overview
• Tea Tree Benefits Hub
• Tea Tree for MRSA
• Tea Tree for Nail Fungus
• Tea Tree for Head Lice
• Acne
• Vitamin A for Skin (Retinoids)
• Vitamin A
• Zinc
• Manuka Honey
• Antibacterial Herbs
• Lavender
• Calendula
• Eczema
• Rosacea
• All Herbs

Back to Table of Contents